Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 265
of 14Next
1:

BRCA2 mutation carriers, reproductive factors and breast cancer risk.

Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson JG, Tulinius H, Eyfjord JE.

Breast Cancer Res. 2003;5(5):R121-8. Epub 2003 Jun 24.

PMID: 12927042 [PubMed - indexed for MEDLINE]

2:

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.

J Natl Cancer Inst. 2006 Jan 18;98(2):116-22.

PMID: 16418514 [PubMed - indexed for MEDLINE]

3:

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.

Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B, Ainsworth P, Gershoni-Baruch R, Foulkes WD, Klijn J, Tung N, Rennert G, Olopade O, Couch F, Wagner T, Olsson H, Sun P, Weitzel JN, Narod SA.

Int J Cancer. 2005 Dec 20;117(6):988-91.

PMID: 15986445 [PubMed - indexed for MEDLINE]

4:

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, Peock S, Evans G, Eccles D, Douglas F, Noguès C, Gauthier-Villars M, Chompret A, Van Leeuwen FE, Kluijt I, Benitez J, Arver B, Olah E, Chang-Claude J; EMBRACE; GENEPSO; GEO-HEBON; IBCCS Collaborators Group.

J Natl Cancer Inst. 2006 Apr 19;98(8):535-44.

PMID: 16622123 [PubMed - indexed for MEDLINE]

5:

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Jernström H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod SA.

J Natl Cancer Inst. 2004 Jul 21;96(14):1094-8.

PMID: 15265971 [PubMed - indexed for MEDLINE]

6:

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.

McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group.

Lancet Oncol. 2007 Jan;8(1):26-34.

PMID: 17196508 [PubMed - indexed for MEDLINE]

7:

Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.

Jernström H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA.

Lancet. 1999 Nov 27;354(9193):1846-50.

PMID: 10584720 [PubMed - indexed for MEDLINE]

8:

The BARD1 Cys557Ser variant and breast cancer risk in Iceland.

Stacey SN, Sulem P, Johannsson OT, Helgason A, Gudmundsson J, Kostic JP, Kristjansson K, Jonsdottir T, Sigurdsson H, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Bergthorsson JT, Amundadottir LT, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K.

PLoS Med. 2006 Jul;3(7):e217.

PMID: 16768547 [PubMed - indexed for MEDLINE]

9:

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Olopado OI, Ghadirian P, Lubinski J, Lynch HT, Isaacs C, Weber B, Kim-Sing C, Ainsworth P, Foulkes WD, Eisen A, Sun P, Narod SA.

Breast Cancer Res. 2005;7(5):R833-43. Epub 2005 Aug 19.

PMID: 16168130 [PubMed - indexed for MEDLINE]

10:

Prostate cancer progression and survival in BRCA2 mutation carriers.

Tryggvadóttir L, Vidarsdóttir L, Thorgeirsson T, Jonasson JG, Olafsdóttir EJ, Olafsdóttir GH, Rafnar T, Thorlacius S, Jonsson E, Eyfjord JE, Tulinius H.

J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. Epub 2007 Jun 12.

PMID: 17565157 [PubMed - indexed for MEDLINE]

11:

Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations.

Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Li FP, Southey MC, Giles GG, McCredie MR, Hopper JL, Whittemore AS.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):350-6.

PMID: 15734957 [PubMed - indexed for MEDLINE]

12:

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers.

Antoniou AC, Shenton A, Maher ER, Watson E, Woodward E, Lalloo F, Easton DF, Evans DG.

Breast Cancer Res. 2006;8(6):R72.

PMID: 17187672 [PubMed - indexed for MEDLINE]

13:

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Narod SA, Dubé MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes WD, Warner E, Kim-Sing C, Olopade O, Tung N, Saal HM, Weitzel J, Merajver S, Gauthier-Villars M, Jernstrom H, Sun P, Brunet JS.

J Natl Cancer Inst. 2002 Dec 4;94(23):1773-9.

PMID: 12464649 [PubMed - indexed for MEDLINE]

14:

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Lubinski J, Lynch HT, Klijn J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domchek S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Baruch R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group, Garber J, Osborne M, Fishman D, McLennan J, McKinnon W, Merajver S, Olsson H, Provencher D, Pasche B, Evans G, Meschino WS, Lemire E, Chudley A, Rayson D, Bellati C.

Breast Cancer Res Treat. 2007 Oct;105(2):221-8. Epub 2007 Jan 24.

PMID: 17245541 [PubMed - indexed for MEDLINE]

15:

Reproductive factors in hereditary breast cancer.

Jernström HC, Johannsson OT, Loman N, Borg A, Olsson H.

Breast Cancer Res Treat. 1999 Dec;58(3):295-301.

PMID: 10718491 [PubMed - indexed for MEDLINE]

16:

Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.

Cavallone L, Arcand SL, Maugard C, Ghadirian P, Mes-Masson AM, Provencher D, Tonin PN.

BMC Cancer. 2008 Apr 10;8:96.

PMID: 18402691 [PubMed - indexed for MEDLINE]

17:

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; for the Institut Curie Breast Cancer Study Group.

Eur J Cancer. 2005 Oct;41(15):2304-11. Epub 2005 Sep 1.

PMID: 16140006 [PubMed - indexed for MEDLINE]

18:

Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years.

Breast Cancer Family Registry; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (Australasia); Ontario Cancer Genetics Network (Canada).

Breast Cancer Res Treat. 2008 May;109(1):67-75. Epub 2007 Oct 31.

PMID: 17972172 [PubMed - indexed for MEDLINE]

19:

Study of a single BRCA2 mutation with high carrier frequency in a small population.

Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, Eyfjörd JE.

Am J Hum Genet. 1997 May;60(5):1079-84.

PMID: 9150155 [PubMed - indexed for MEDLINE]

20:

Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.

Hartge P, Chatterjee N, Wacholder S, Brody LC, Tucker MA, Struewing JP.

Epidemiology. 2002 May;13(3):255-61.

PMID: 11964925 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 265
of 14Next